Figure 3From: Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]bar chart showing percentage change from baseline to placebo and experimental conditions.Back to article page